| Target Price | $10.20 |
| Price | $4.13 |
| Potential |
146.97%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Graphite Bio Inc 2027 .
The average Graphite Bio Inc target price is $10.20.
This is
146.97%
register free of charge
$63.00
1,425.42%
register free of charge
$7.07
71.19%
register free of charge
|
|
| A rating was issued by 13 analysts: 10 Analysts recommend Graphite Bio Inc to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Graphite Bio Inc stock has an average upside potential 2027 of
146.97%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 19.09 | 17.65 |
| 7.55% | ||
| EBITDA Margin | -475.90% | -644.23% |
| 35.37% | ||
| Net Margin | -430.23% | -741.91% |
| 72.45% |
9 Analysts have issued a sales forecast Graphite Bio Inc 2026 . The average Graphite Bio Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Graphite Bio Inc EBITDA forecast 2026. The average Graphite Bio Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Graphite Bio Inc Analysts have issued a net profit forecast 2026. The average Graphite Bio Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.85 | -4.17 |
| 21.79% | 46.32% | |
| P/E | negative | |
| EV/Sales | negative |
9 Analysts have issued a Graphite Bio Inc forecast for earnings per share. The average Graphite Bio Inc EPS is
This results in the following potential growth metrics and future valuations:
Graphite Bio Inc...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 12 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 07 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | May 13 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | May 12 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 12 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 21 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Mar 26 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 12 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 07 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
May 13 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 12 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 12 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 21 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Mar 26 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


